John R Parker

Title: John R Parker: Innovator in Protein Reagents

Introduction

John R Parker is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of biochemistry, particularly in the development of protein reagents. His innovative work has led to the creation of a patent that enhances the stability and usability of these reagents in various applications.

Latest Patents

John R Parker holds a patent for "Pre-activated proteins for labelling oligonucleotide probes." This invention provides pre-activated stable protein reagents that can be synthesized through the reaction of proteins and heterobifunctional linkers. These reagents exhibit extended stability, especially after lyophilisation, making them ideal for use in assay kits. They can form conjugates with proteins, such as antibodies, or with polynucleotides, including oligonucleotide probes. This advancement is crucial for improving the efficiency and reliability of biochemical assays.

Career Highlights

Parker is associated with Zeneca Limited, a company known for its focus on innovative pharmaceutical and biotechnology solutions. His work at Zeneca has allowed him to contribute to cutting-edge research and development in the field of protein chemistry. His expertise and dedication have positioned him as a valuable asset within the company.

Collaborations

One of his notable collaborators is Andrew John Garman. Together, they have worked on various projects that leverage their combined expertise in biochemistry and protein engineering.

Conclusion

John R Parker's contributions to the field of protein reagents exemplify the impact of innovation in biochemistry. His patent for pre-activated proteins represents a significant advancement that enhances the stability and functionality of reagents used in laboratory settings. His work continues to influence the development of more effective biochemical assays.